Lilly PACKAGE LABEL - Zepbound Multi-Dose Vial - 5 mg/0.6 mL Dose (20 mg/2.4 mL [8.33 mg/mL]) PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Rx Only NDC 0002-6103-11 Zepbound (tirzepatide) injection 20 mg/2.4 mL (8.33 mg/mL) ATTENTION: Contains 4 doses of 5 mg/0.6 mL 2.4 mL MULTI-DOSE VIAL For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient
By reducing calories and excess pounds, you also alleviate the pressure on your blood vessels, which improves circulation and delivers more nutrients to your heart and other vital organs
Peer review Peer review information Nature Communications thanks Mitsuyasu Hasebe, Hiroaki Mano, Andrej Pavlovic and Michael Wudick for their contribution to the peer review of this work
What to expect when using Semaglutide GLP-1
When used with insulin or sulfonylureas, there is an increased risk of low blood sugar (hypoglycemia)
As we investigate whether semaglutide, including Ozempic, affects the menstrual cycle, its crucial to examine how this medication may impact hormone levels in the body